On 2025-2-8 Global Info Research released【Global Blood Banking and Blood Products Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031】. This report includes an overview of the development of the Blood Banking and Blood Products industry chain, the market status of Consumer Electronics (Nickel-Zinc Ferrite Core, Mn-Zn Ferrite Core), Household Appliances (Nickel-Zinc Ferrite Core, Mn-Zn Ferrite Core), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Blood Banking and Blood Products.
Sample Report Request Blood Banking and Blood Products
https://www.globalinforesearch.com/reports/2412560/blood-banking-and-blood-products
According to our (Global Info Research) latest study, the global Blood Banking and Blood Products market size was valued at US$ 58980 million in 2024 and is forecast to a readjusted size of USD 93530 million by 2031 with a CAGR of 6.9% during review period.
Blood banking is the process that takes place in the lab to make sure that donated blood, or blood products, are safe before they are used in blood transfusions and other medical procedures. Blood banking includes typing the blood for transfusion and testing for infectious diseases. A blood product is any therapeutic substance prepared from human blood. This includes: whole blood; blood components; and plasma derivatives. Whole blood is not commonly used in transfusion medicine.
Blood products refer to various human plasma protein products, including albumin, immunoglobulin, coagulation factors, etc. The raw material of blood products is plasma. 92% - 93% of human plasma is water, and only 7% - 8% is protein. Blood products are made by separating and purifying this part of protein.
The primary driver of the blood banking market is the increasing prevalence of chronic diseases and the rising number of surgical procedures globally. Conditions such as cancer, anemia, and trauma often require blood transfusions, boosting the demand for blood and blood products. Additionally, advancements in medical technology, such as improved blood preservation techniques and the development of blood substitutes, have enhanced the efficiency of blood banking systems, further contributing to market growth. One major challenge in the blood banking market is the risk of blood contamination and the transmission of infectious diseases. Despite stringent screening processes, there remains a possibility of contamination, especially in regions with less advanced healthcare systems. Furthermore, the high cost of blood testing and the maintenance of blood banks, coupled with the difficulty in ensuring a consistent blood supply due to low donation rates in some areas, presents significant obstacles to market expansion.
The growing prevalence of immunodeficiency disorders, hemophilia, and other chronic diseases that require plasma-derived therapies is a key driver of the blood product market. Blood products, such as immunoglobulins, clotting factors, and albumin, are essential in treating conditions where patients have compromised immune systems or bleeding disorders. Furthermore, the increasing use of plasma products in emergency care and surgical procedures, along with advancements in fractionation technologies, is boosting market demand. A major challenge in the blood product market is the high cost and complexity of the plasma collection and fractionation process. The production of blood products requires strict regulatory compliance and advanced facilities to ensure the purity and safety of these therapies, driving up costs. Additionally, fluctuations in plasma donation rates and the need for extensive screening to prevent contamination or the spread of infectious diseases can lead to supply shortages, especially in regions with underdeveloped healthcare infrastructure.
Market segment by Type：RBCs、Plts、Plasma、Whole Blood、Plasma Fractionation Products
Market segment by Application：Hospital、Clinic、Retail Pharmacy、Others
Major players covered： America’s Blood Centers、Japan Red Cross Society、American Red Cross、Australia Red Cross、Red Cross Society of China、NHS Blood and Transplant、New York Blood Center、Canadian Blood Services、Sanquin Blood Supply Foundation、Blood Bank of Alaska、Vitalant、National Blood Transfusion Council、Takeda、CSL、Grifols、Octapharma、Kedrion、LFB Group、Biotest、BPL、RAAS、CBPO、Hualan Bio、Tiantan Bio、Shuanglin Bio、Boya Bio、Yuanda Shuyang、Weiguang Bio、Nanyue Bio、KM Biologics
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Blood Banking and Blood Products by Type
1.3.1 Overview: Global Blood Banking and Blood Products Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Blood Banking and Blood Products Consumption Value Market Share by Type in 2024
1.3.3 RBCs
1.3.4 Plts
1.3.5 Plasma
1.3.6 Whole Blood
1.3.7 Plasma Fractionation Products
1.4 Global Blood Banking and Blood Products Market by Application
1.4.1 Overview: Global Blood Banking and Blood Products Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Retail Pharmacy
1.4.5 Others
1.5 Global Blood Banking and Blood Products Market Size & Forecast
1.6 Global Blood Banking and Blood Products Market Size and Forecast by Region
1.6.1 Global Blood Banking and Blood Products Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Blood Banking and Blood Products Market Size by Region, (2020-2031)
1.6.3 North America Blood Banking and Blood Products Market Size and Prospect (2020-2031)
1.6.4 Europe Blood Banking and Blood Products Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Blood Banking and Blood Products Market Size and Prospect (2020-2031)
1.6.6 South America Blood Banking and Blood Products Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Blood Banking and Blood Products Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 America’s Blood Centers
2.1.1 America’s Blood Centers Details
2.1.2 America’s Blood Centers Major Business
2.1.3 America’s Blood Centers Blood Banking and Blood Products Product and Solutions
2.1.4 America’s Blood Centers Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 America’s Blood Centers Recent Developments and Future Plans
2.2 Japan Red Cross Society
2.2.1 Japan Red Cross Society Details
2.2.2 Japan Red Cross Society Major Business
2.2.3 Japan Red Cross Society Blood Banking and Blood Products Product and Solutions
2.2.4 Japan Red Cross Society Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Japan Red Cross Society Recent Developments and Future Plans
2.3 American Red Cross
2.3.1 American Red Cross Details
2.3.2 American Red Cross Major Business
2.3.3 American Red Cross Blood Banking and Blood Products Product and Solutions
2.3.4 American Red Cross Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 American Red Cross Recent Developments and Future Plans
2.4 Australia Red Cross
2.4.1 Australia Red Cross Details
2.4.2 Australia Red Cross Major Business
2.4.3 Australia Red Cross Blood Banking and Blood Products Product and Solutions
2.4.4 Australia Red Cross Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Australia Red Cross Recent Developments and Future Plans
2.5 Red Cross Society of China
2.5.1 Red Cross Society of China Details
2.5.2 Red Cross Society of China Major Business
2.5.3 Red Cross Society of China Blood Banking and Blood Products Product and Solutions
2.5.4 Red Cross Society of China Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Red Cross Society of China Recent Developments and Future Plans
2.6 NHS Blood and Transplant
2.6.1 NHS Blood and Transplant Details
2.6.2 NHS Blood and Transplant Major Business
2.6.3 NHS Blood and Transplant Blood Banking and Blood Products Product and Solutions
2.6.4 NHS Blood and Transplant Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 NHS Blood and Transplant Recent Developments and Future Plans
2.7 New York Blood Center
2.7.1 New York Blood Center Details
2.7.2 New York Blood Center Major Business
2.7.3 New York Blood Center Blood Banking and Blood Products Product and Solutions
2.7.4 New York Blood Center Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 New York Blood Center Recent Developments and Future Plans
2.8 Canadian Blood Services
2.8.1 Canadian Blood Services Details
2.8.2 Canadian Blood Services Major Business
2.8.3 Canadian Blood Services Blood Banking and Blood Products Product and Solutions
2.8.4 Canadian Blood Services Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Canadian Blood Services Recent Developments and Future Plans
2.9 Sanquin Blood Supply Foundation
2.9.1 Sanquin Blood Supply Foundation Details
2.9.2 Sanquin Blood Supply Foundation Major Business
2.9.3 Sanquin Blood Supply Foundation Blood Banking and Blood Products Product and Solutions
2.9.4 Sanquin Blood Supply Foundation Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Sanquin Blood Supply Foundation Recent Developments and Future Plans
2.10 Blood Bank of Alaska
2.10.1 Blood Bank of Alaska Details
2.10.2 Blood Bank of Alaska Major Business
2.10.3 Blood Bank of Alaska Blood Banking and Blood Products Product and Solutions
2.10.4 Blood Bank of Alaska Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Blood Bank of Alaska Recent Developments and Future Plans
2.11 Vitalant
2.11.1 Vitalant Details
2.11.2 Vitalant Major Business
2.11.3 Vitalant Blood Banking and Blood Products Product and Solutions
2.11.4 Vitalant Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Vitalant Recent Developments and Future Plans
2.12 National Blood Transfusion Council
2.12.1 National Blood Transfusion Council Details
2.12.2 National Blood Transfusion Council Major Business
2.12.3 National Blood Transfusion Council Blood Banking and Blood Products Product and Solutions
2.12.4 National Blood Transfusion Council Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 National Blood Transfusion Council Recent Developments and Future Plans
2.13 Takeda
2.13.1 Takeda Details
2.13.2 Takeda Major Business
2.13.3 Takeda Blood Banking and Blood Products Product and Solutions
2.13.4 Takeda Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Takeda Recent Developments and Future Plans
2.14 CSL
2.14.1 CSL Details
2.14.2 CSL Major Business
2.14.3 CSL Blood Banking and Blood Products Product and Solutions
2.14.4 CSL Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 CSL Recent Developments and Future Plans
2.15 Grifols
2.15.1 Grifols Details
2.15.2 Grifols Major Business
2.15.3 Grifols Blood Banking and Blood Products Product and Solutions
2.15.4 Grifols Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Grifols Recent Developments and Future Plans
2.16 Octapharma
2.16.1 Octapharma Details
2.16.2 Octapharma Major Business
2.16.3 Octapharma Blood Banking and Blood Products Product and Solutions
2.16.4 Octapharma Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Octapharma Recent Developments and Future Plans
2.17 Kedrion
2.17.1 Kedrion Details
2.17.2 Kedrion Major Business
2.17.3 Kedrion Blood Banking and Blood Products Product and Solutions
2.17.4 Kedrion Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Kedrion Recent Developments and Future Plans
2.18 LFB Group
2.18.1 LFB Group Details
2.18.2 LFB Group Major Business
2.18.3 LFB Group Blood Banking and Blood Products Product and Solutions
2.18.4 LFB Group Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 LFB Group Recent Developments and Future Plans
2.19 Biotest
2.19.1 Biotest Details
2.19.2 Biotest Major Business
2.19.3 Biotest Blood Banking and Blood Products Product and Solutions
2.19.4 Biotest Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Biotest Recent Developments and Future Plans
2.20 BPL
2.20.1 BPL Details
2.20.2 BPL Major Business
2.20.3 BPL Blood Banking and Blood Products Product and Solutions
2.20.4 BPL Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 BPL Recent Developments and Future Plans
2.21 RAAS
2.21.1 RAAS Details
2.21.2 RAAS Major Business
2.21.3 RAAS Blood Banking and Blood Products Product and Solutions
2.21.4 RAAS Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 RAAS Recent Developments and Future Plans
2.22 CBPO
2.22.1 CBPO Details
2.22.2 CBPO Major Business
2.22.3 CBPO Blood Banking and Blood Products Product and Solutions
2.22.4 CBPO Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 CBPO Recent Developments and Future Plans
2.23 Hualan Bio
2.23.1 Hualan Bio Details
2.23.2 Hualan Bio Major Business
2.23.3 Hualan Bio Blood Banking and Blood Products Product and Solutions
2.23.4 Hualan Bio Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.23.5 Hualan Bio Recent Developments and Future Plans
2.24 Tiantan Bio
2.24.1 Tiantan Bio Details
2.24.2 Tiantan Bio Major Business
2.24.3 Tiantan Bio Blood Banking and Blood Products Product and Solutions
2.24.4 Tiantan Bio Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.24.5 Tiantan Bio Recent Developments and Future Plans
2.25 Shuanglin Bio
2.25.1 Shuanglin Bio Details
2.25.2 Shuanglin Bio Major Business
2.25.3 Shuanglin Bio Blood Banking and Blood Products Product and Solutions
2.25.4 Shuanglin Bio Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.25.5 Shuanglin Bio Recent Developments and Future Plans
2.26 Boya Bio
2.26.1 Boya Bio Details
2.26.2 Boya Bio Major Business
2.26.3 Boya Bio Blood Banking and Blood Products Product and Solutions
2.26.4 Boya Bio Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.26.5 Boya Bio Recent Developments and Future Plans
2.27 Yuanda Shuyang
2.27.1 Yuanda Shuyang Details
2.27.2 Yuanda Shuyang Major Business
2.27.3 Yuanda Shuyang Blood Banking and Blood Products Product and Solutions
2.27.4 Yuanda Shuyang Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.27.5 Yuanda Shuyang Recent Developments and Future Plans
2.28 Weiguang Bio
2.28.1 Weiguang Bio Details
2.28.2 Weiguang Bio Major Business
2.28.3 Weiguang Bio Blood Banking and Blood Products Product and Solutions
2.28.4 Weiguang Bio Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.28.5 Weiguang Bio Recent Developments and Future Plans
2.29 Nanyue Bio
2.29.1 Nanyue Bio Details
2.29.2 Nanyue Bio Major Business
2.29.3 Nanyue Bio Blood Banking and Blood Products Product and Solutions
2.29.4 Nanyue Bio Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.29.5 Nanyue Bio Recent Developments and Future Plans
2.30 KM Biologics
2.30.1 KM Biologics Details
2.30.2 KM Biologics Major Business
2.30.3 KM Biologics Blood Banking and Blood Products Product and Solutions
2.30.4 KM Biologics Blood Banking and Blood Products Revenue, Gross Margin and Market Share (2020-2025)
2.30.5 KM Biologics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Blood Banking and Blood Products Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Blood Banking and Blood Products by Company Revenue
3.2.2 Top 3 Blood Banking and Blood Products Players Market Share in 2024
3.2.3 Top 6 Blood Banking and Blood Products Players Market Share in 2024
3.3 Blood Banking and Blood Products Market: Overall Company Footprint Analysis
3.3.1 Blood Banking and Blood Products Market: Region Footprint
3.3.2 Blood Banking and Blood Products Market: Company Product Type Footprint
3.3.3 Blood Banking and Blood Products Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Blood Banking and Blood Products Consumption Value and Market Share by Type (2020-2025)
4.2 Global Blood Banking and Blood Products Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Blood Banking and Blood Products Consumption Value Market Share by Application (2020-2025)
5.2 Global Blood Banking and Blood Products Market Forecast by Application (2026-2031)
6 North America
6.1 North America Blood Banking and Blood Products Consumption Value by Type (2020-2031)
6.2 North America Blood Banking and Blood Products Market Size by Application (2020-2031)
6.3 North America Blood Banking and Blood Products Market Size by Country
6.3.1 North America Blood Banking and Blood Products Consumption Value by Country (2020-2031)
6.3.2 United States Blood Banking and Blood Products Market Size and Forecast (2020-2031)
6.3.3 Canada Blood Banking and Blood Products Market Size and Forecast (2020-2031)
6.3.4 Mexico Blood Banking and Blood Products Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Blood Banking and Blood Products Consumption Value by Type (2020-2031)
7.2 Europe Blood Banking and Blood Products Consumption Value by Application (2020-2031)
7.3 Europe Blood Banking and Blood Products Market Size by Country
7.3.1 Europe Blood Banking and Blood Products Consumption Value by Country (2020-2031)
7.3.2 Germany Blood Banking and Blood Products Market Size and Forecast (2020-2031)
7.3.3 France Blood Banking and Blood Products Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Blood Banking and Blood Products Market Size and Forecast (2020-2031)
7.3.5 Russia Blood Banking and Blood Products Market Size and Forecast (2020-2031)
7.3.6 Italy Blood Banking and Blood Products Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Blood Banking and Blood Products Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Blood Banking and Blood Products Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Blood Banking and Blood Products Market Size by Region
8.3.1 Asia-Pacific Blood Banking and Blood Products Consumption Value by Region (2020-2031)
8.3.2 China Blood Banking and Blood Products Market Size and Forecast (2020-2031)
8.3.3 Japan Blood Banking and Blood Products Market Size and Forecast (2020-2031)
8.3.4 South Korea Blood Banking and Blood Products Market Size and Forecast (2020-2031)
8.3.5 India Blood Banking and Blood Products Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Blood Banking and Blood Products Market Size and Forecast (2020-2031)
8.3.7 Australia Blood Banking and Blood Products Market Size and Forecast (2020-2031)
9 South America
9.1 South America Blood Banking and Blood Products Consumption Value by Type (2020-2031)
9.2 South America Blood Banking and Blood Products Consumption Value by Application (2020-2031)
9.3 South America Blood Banking and Blood Products Market Size by Country
9.3.1 South America Blood Banking and Blood Products Consumption Value by Country (2020-2031)
9.3.2 Brazil Blood Banking and Blood Products Market Size and Forecast (2020-2031)
9.3.3 Argentina Blood Banking and Blood Products Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Blood Banking and Blood Products Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Blood Banking and Blood Products Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Blood Banking and Blood Products Market Size by Country
10.3.1 Middle East & Africa Blood Banking and Blood Products Consumption Value by Country (2020-2031)
10.3.2 Turkey Blood Banking and Blood Products Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Blood Banking and Blood Products Market Size and Forecast (2020-2031)
10.3.4 UAE Blood Banking and Blood Products Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Blood Banking and Blood Products Market Drivers
11.2 Blood Banking and Blood Products Market Restraints
11.3 Blood Banking and Blood Products Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Blood Banking and Blood Products Industry Chain
12.2 Blood Banking and Blood Products Upstream Analysis
12.3 Blood Banking and Blood Products Midstream Analysis
12.4 Blood Banking and Blood Products Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
About Us:
GlobaI Info Research
Web: https://www.globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
US: 001-347 966 1888
Email: report@globalinforesearch.com
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
